Phibro Animal Health Corporation logo PAHC - Phibro Animal Health Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 6
HOLD 4
SELL 4
STRONG
SELL 0
| PRICE TARGET: $49.00 DETAILS
HIGH: $49.00
LOW: $49.00
MEDIAN: $49.00
CONSENSUS: $49.00
UPSIDE: 47.32%

Stock News

Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference. Executive Vice President, Corporate Strategy & CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 27, 2026, at 9:45 AM ET at Lotte New York Palace in New York. The live audio presentation will be available on the.

May 21, 2026 12:30 PM • businesswire.com
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference. Executive Vice President, Corporate Strategy & CEO Designate Daniel Bendheim; Chief Operating Officer, Larry Miller and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 13, 2026, at 1:40 PM ET at Wynn and Encore in Las Vegas. The live audio presentation will be availab.

May 07, 2026 12:30 PM • businesswire.com
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for the year ending June 30, 2026. Highlights for the three months ended March 31, 2026 (compared to the three months ended March 31, 2025): Net sales of $383.5 million, an increase of $35.7 million, or 10% Net income of $24.0 million, an increase of $3.1 million, or 15% Dilute.

May 06, 2026 12:30 PM • businesswire.com
Phibro Animal Health Corporation Declares Quarterly Dividend

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 24, 2026, to stockholders of record at the close of business on June 3, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with livest.

May 05, 2026 12:30 PM • businesswire.com
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership

Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP), a companywide initiative designed to help animal protein, dairy and petfood producers address greenhouse gas emissions through practical, science-based solutions that integrate seamlessly into existing feed and production systems. As part of the SSP launch, Phibro is introducing Verratain™ Verified Sustainability Solutions, the Company's fir.

May 05, 2026 12:15 PM • businesswire.com
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 6, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 7, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-202.

Apr 29, 2026 12:30 PM • businesswire.com
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications. The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed additives containing antimicrobials classified as importan.

Apr 27, 2026 12:30 PM • businesswire.com

Price Targets